Buy CBD Oil
← Back to BlogResearch

Fenbendazole and Cancer Research - What Studies Show

•10 min read

The Science Behind Fenbendazole


Fenbendazole is a benzimidazole compound primarily used as an anthelmintic (dewormer) in veterinary medicine. However, laboratory research has explored its potential anti-cancer properties.


Key Research Findings


#### Laboratory Studies


Research has shown fenbendazole may:

  • Inhibit microtubule polymerization in cancer cells
  • Induce apoptosis (cell death) in certain cancer cell lines
  • Potentially slow tumor growth in animal models

    • #### MD Anderson Connection


    The University of Texas MD Anderson Cancer Center conducted preliminary research on benzimidazole compounds, including fenbendazole, exploring their effects on cancer cells.


    Important Caveats


    1. **Preclinical data only**: Most research is limited to cell cultures and animal studies

    2. **Human trials lacking**: No large-scale clinical trials have proven effectiveness

    3. **Not FDA-approved**: Fenbendazole is not approved for cancer treatment

    4. **Individual results vary**: What works in laboratories may not work in humans


    Published Studies


  • Some peer-reviewed studies have explored fenbendazole's mechanism of action
  • Case reports exist of individual patients using the protocol
  • South Korea has documented adverse cases requiring medical attention

    • Our Approach


    We present the research objectively, highlighting both potential mechanisms and the lack of human clinical trial data. Always consult healthcare professionals.